Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Accelerate Diagnosti (AXDX)

Accelerate Diagnosti (AXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 29,051
  • Shares Outstanding, K 25,044
  • Annual Sales, $ 12,060 K
  • Annual Income, $ -61,620 K
  • EBIT $ -38 M
  • EBITDA $ -31 M
  • 60-Month Beta 0.56
  • Price/Sales 2.41
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 616.70% ( +190.69%)
  • Historical Volatility 58.66%
  • IV Percentile 96%
  • IV Rank 67.73%
  • IV High 890.29% on 02/06/24
  • IV Low 42.53% on 12/20/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 27
  • Volume Avg (30-Day) 7
  • Put/Call OI Ratio 0.12
  • Today's Open Interest 436
  • Open Int (30-Day) 425

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.50
  • Number of Estimates 1
  • High Estimate -0.50
  • Low Estimate -0.50
  • Prior Year -0.89
  • Growth Rate Est. (year over year) +43.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1200 +3.57%
on 12/23/24
1.8800 -38.30%
on 12/04/24
-0.4800 (-29.27%)
since 11/22/24
3-Month
1.1200 +3.57%
on 12/23/24
2.0400 -43.14%
on 11/06/24
-0.3700 (-24.18%)
since 09/23/24
52-Week
0.7300 +58.90%
on 04/18/24
4.3500 -73.33%
on 12/26/23
-3.1700 (-73.21%)
since 12/22/23

Most Recent Stories

More News
Insider Purchase: Director at $AXDX (AXDX) Buys 200,000 Shares

JOHN PATIENCE, a director at $AXDX ($AXDX), bought 200,000 shares of the company on 12-03-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their...

AXDX : 1.1300 (-2.59%)
Accelerate Diagnostics: Q3 Earnings Snapshot

Accelerate Diagnostics: Q3 Earnings Snapshot

AXDX : 1.1300 (-2.59%)
US settles with billionaire Carl Icahn for using company to secure personal loans worth billions

Billionaire Carl Icahn and his company were charged by U.S. regulators with failing to disclose personal loans worth billions of dollars that were secured using securities of Icahn Enterprises as collateral...

AXDX : 1.1300 (-2.59%)
Accelerate Diagnostics: Q2 Earnings Snapshot

Accelerate Diagnostics: Q2 Earnings Snapshot

AXDX : 1.1300 (-2.59%)
Accelerate Diagnostics: Q1 Earnings Snapshot

Accelerate Diagnostics: Q1 Earnings Snapshot

AXDX : 1.1300 (-2.59%)
Accelerate Diagnostics: Q3 Earnings Snapshot

Accelerate Diagnostics: Q3 Earnings Snapshot

AXDX : 1.1300 (-2.59%)
Accelerate Diagnostics: Q2 Earnings Snapshot

Accelerate Diagnostics: Q2 Earnings Snapshot

AXDX : 1.1300 (-2.59%)
Accelerate Diagnostics Reports Second Quarter 2023 Financial Results

/PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the second quarter for the period ended June 30, 2023....

AXDX : 1.1300 (-2.59%)
Accelerate Diagnostics Scheduled Call to Review 2023 Second Quarter Results

/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Thursday, August 10, 2023, at 4:30 p....

AXDX : 1.1300 (-2.59%)
Accelerate Diagnostics: Q1 Earnings Snapshot

Accelerate Diagnostics: Q1 Earnings Snapshot

AXDX : 1.1300 (-2.59%)

Business Summary

Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections...

See More

Key Turning Points

3rd Resistance Point 1.3265
2nd Resistance Point 1.2812
1st Resistance Point 1.2206
Last Price 1.1300
1st Support Level 1.1147
2nd Support Level 1.0694
3rd Support Level 1.0088

See More

52-Week High 4.3500
Fibonacci 61.8% 2.9672
Fibonacci 50% 2.5400
Fibonacci 38.2% 2.1128
Last Price 1.1300
52-Week Low 0.7300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar